title: DTB Select: 3 | March 2014.
abstract: Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned. We also include comments on, for example, the strengths of the information, whether it contains anomalies, ambiguities, apparent error or omissions, or whether or how it affects current practice.
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D001334:Automobile Driving / Q000331:legislation & jurisprudence; D002648:Child; D059350:Chronic Pain / Q000628:therapy; D000077144:Clopidogrel; D006509:Hepatitis B / Q000175:diagnosis; D006635:Histamine H2 Antagonists / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000628:therapy; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D054328:Proton Pump Inhibitors / Q000009:adverse effects; D012141:Respiratory Tract Infections / Q000503:physiopathology; D000069283:Rituximab; D013876:Thiophenes / Q000627:therapeutic use; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D013876:Thiophenes; C081587:strontium ranelate; D000069283:Rituximab; D000077144:Clopidogrel; D013988:Ticlopidine